NEWTON, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, today announced that the U.S. Food & Dr

NeurodigitX, the innovative digital health company, announced today a new comprehensive platform called Plastic Health™ that allows a powerful mainstream bloodless assessment of inflammation levels, first targeting the current pandemic, in an effort to supplement and enhance vaccine immunization strategies. Nearly 50,000 scientific studies have been released on HRV (Heart Rate Variability), which affords a noninvasive assessment of inflammation of brain and bodily function. Ne

Prescient Surgical has been awarded a group purchasing agreement for a Breakthrough Technology contract with Premier. Effective November 1, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the CleanCision Wound Retraction and Protection device, the first in a new class of advanced technology that fights and defends against the sources of surgical site infection (SSI). "We are thrilled to

ELITechGroup MDx ELITechGroup MDx LLC, a leading global provider of molecular diagnostic testing products, announced it submitted the SARS-CoV-2 Plus ELITe MGB® Assay to the U.S. Food & Drug Association's (FDA's) for Emergency Use Authorization (EUA), following the Molecular Diagnostic Template for Commercial Manufacturers. The SARS-CoV-2 Plus ELITe MGB® Assay is for the in vitro qualitative detection and differentiation of RNA from the Severe Acute Respiratory Syndrome Co

Genesis Innovation Group's cultivate(MD) Capital Fund II LP, a fund focused on investments into early stage healthcare companies with innovative technologies, announces that one of their portfolio companies, Tucson-based SafKan Health, a medical device company that has developed the first automated ear cleaning device, the OtoSetTM Ear Cleaning System has received its 510(k) clearance from the US Food and Drug Administration. 35 million Americans are affected by impacted earwax,

BATON ROUGE, La., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the Jefferies Virtual London Healthcare Conference on Tuesday, November 17, 2020. The presentation will

SEKISUI Diagnostics announces that it has received the CE (Conformité Européenne) mark for the OSOM ® Ultra Plus Flu A&B test and has begun commercialization in Europe.   The test uses traditional lateral flow technology with performance close to or better than the sensitivity of other reader-based tests without using an instrument. It is intended for the qualitative detection of influenza type A and type B nucleoprotein antigens directly from nasal or nas

Business Wire IndiaWipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced that it will deliver managed Software-Defined Wide Area Network (SD-WAN) transformation services to Olympus leveraging Cisco technology. Headquartered in Tokyo, Japan, Olympus is passionate about the solutions it creates for the medical, life sciences, and industrial equipment in

Sofwave Medical, the emerging leader of energy-based non-invasive aesthetic medical devices, announced that it has secured CE Mark (Conformité Européenne) for its next-generation Sofwave system which was approved for use for the treatment of fine lines and wrinkles in the EU. Sofwave's state-of-the-art Synchronous Ultrasound Parallel Beam technology SUPERBTM addresses the growing demand for non-invasive treatments that deliver improvement in skin laxity which resul

SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, today announced that it has extended its collaboration agreement with GlaxoSmithKline plc